CaMKII and a Failing Strategy for Growth in Heart

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2009 May 8

PMID 19422097

Citations 35

Authors

Mark E Anderson

Affiliations

Soon will be listed here.

Abstract

Patients with systolic left ventricular dysfunction die progressively from congestive heart failure or die suddenly from cardiac arrhythmias. Myocardial hypertrophy is an early event in most forms of heart failure, but the majority of patients with myocardial hypertrophy do not develop heart failure. Developing improved therapies for targeting the cell signaling pathways that enable this deadly transition from early myocardial insult to heart failure and sudden death is a key goal for improving public health. In this issue of the JCI, Ling and colleagues provide new evidence that activation of the multifunctional Ca(2+)/calmodulin-dependent kinase IIdelta is a decisive step on the path to heart failure in mice (see the related article beginning on page 1230).

Citing Articles

Importance of N2BA Titin in Maintaining Cardiac Homeostasis and Its Role in Dilated Cardiomyopathy.

van der Pijl R, Nusayr E, Strom J, Slater R, Gohlke J, Hourani Z Circ Heart Fail. 2025; :e012083.

PMID: 39932400 PMC: 11905908. DOI: 10.1161/CIRCHEARTFAILURE.124.012083.

Forward genetic screen using a gene-breaking trap approach identifies a novel role of -associated RNA transcript () in zebrafish heart function.

Angom R, Joshi A, Patowary A, Sivadas A, Ramasamy S, K V S Front Cell Dev Biol. 2024; 12:1339292.

PMID: 38533084 PMC: 10964321. DOI: 10.3389/fcell.2024.1339292.

Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension.

Sun X, Cao J, Chen Z, Liu Y, VonCannon J, Cheng H Heliyon. 2023; 9(7):e17851.

PMID: 37456012 PMC: 10344767. DOI: 10.1016/j.heliyon.2023.e17851.

CAMK2D De Novo Missense Variant in Patient with Syndromic Neurodevelopmental Disorder: A Case Report.

Tolmacheva E, Shubina J, Kochetkova T, Ushakova L, Bokerija E, Vasiliev G Genes (Basel). 2023; 14(6).

PMID: 37372357 PMC: 10298453. DOI: 10.3390/genes14061177.

Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice.

Mikhailov A, Liu Y, Cheng H, Lin J, Cheng C Heliyon. 2022; 8(11):e11653.

PMID: 36411910 PMC: 9674542. DOI: 10.1016/j.heliyon.2022.e11653.

References

Gwathmey J, Copelas L, Mackinnon R, Schoen F, Feldman M, Grossman W . Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987; 61(1):70-6. DOI: 10.1161/01.res.61.1.70. View

Lu J, McKinsey T, Nicol R, Olson E . Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A. 2000; 97(8):4070-5. PMC: 18151. DOI: 10.1073/pnas.080064097. View

Dzhura I, Wu Y, Colbran R, Balser J, Anderson M . Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol. 2000; 2(3):173-7. DOI: 10.1038/35004052. View

Schworer C, Colbran R, Soderling T . Reversible generation of a Ca2+-independent form of Ca2+(calmodulin)-dependent protein kinase II by an autophosphorylation mechanism. J Biol Chem. 1986; 261(19):8581-4. View

Velagaleti R, Pencina M, Murabito J, Wang T, Parikh N, DAgostino R . Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008; 118(20):2057-62. PMC: 2729712. DOI: 10.1161/CIRCULATIONAHA.108.784215. View

Vega R, Harrison B, Meadows E, Roberts C, Papst P, Olson E . Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol. 2004; 24(19):8374-85. PMC: 516754. DOI: 10.1128/MCB.24.19.8374-8385.2004. View

Drazner M, Rame J, Marino E, Gottdiener J, Kitzman D, Gardin J . Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol. 2004; 43(12):2207-15. DOI: 10.1016/j.jacc.2003.11.064. View

Maack C, Kartes T, Kilter H, Schafers H, Nickenig G, Bohm M . Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation. 2003; 108(13):1567-74. DOI: 10.1161/01.CIR.0000091084.46500.BB. View

Backs J, Backs T, Neef S, Kreusser M, Lehmann L, Patrick D . The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A. 2009; 106(7):2342-7. PMC: 2650158. DOI: 10.1073/pnas.0813013106. View

10.

Ai X, Curran J, R Shannon T, Bers D, Pogwizd S . Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res. 2005; 97(12):1314-22. DOI: 10.1161/01.RES.0000194329.41863.89. View

11.

Zhang R, Khoo M, Wu Y, Yang Y, Grueter C, Ni G . Calmodulin kinase II inhibition protects against structural heart disease. Nat Med. 2005; 11(4):409-17. DOI: 10.1038/nm1215. View

12.

Mosterd A, DAgostino R, Silbershatz H, Sytkowski P, Kannel W, Grobbee D . Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med. 1999; 340(16):1221-7. DOI: 10.1056/NEJM199904223401601. View

13.

Levy D, Larson M, Vasan R, Kannel W, Ho K . The progression from hypertension to congestive heart failure. JAMA. 1996; 275(20):1557-62. View

14.

Wagner S, Dybkova N, Rasenack E, Jacobshagen C, Fabritz L, Kirchhof P . Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J Clin Invest. 2006; 116(12):3127-38. PMC: 1654201. DOI: 10.1172/JCI26620. View

15.

Khoo M, Li J, Singh M, Yang Y, Kannankeril P, Wu Y . Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Circulation. 2006; 114(13):1352-9. DOI: 10.1161/CIRCULATIONAHA.106.644583. View

16.

Zhu W, Wang S, Chakir K, Yang D, Zhang T, Brown J . Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest. 2003; 111(5):617-25. PMC: 151893. DOI: 10.1172/JCI16326. View

17.

Yang Y, Zhu W, Joiner M, Zhang R, Oddis C, Hou Y . Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am J Physiol Heart Circ Physiol. 2006; 291(6):H3065-75. DOI: 10.1152/ajpheart.00353.2006. View

18.

Parikh N, Gona P, Larson M, Wang T, Newton-Cheh C, Levy D . Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J. 2007; 28(21):2644-52. DOI: 10.1093/eurheartj/ehm399. View

19.

Benedict C, Shelton B, Johnstone D, Francis G, Greenberg B, KONSTAM M . Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation. 1996; 94(4):690-7. DOI: 10.1161/01.cir.94.4.690. View

20.

Zhang T, Maier L, Dalton N, Miyamoto S, Ross Jr J, Bers D . The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res. 2003; 92(8):912-9. DOI: 10.1161/01.RES.0000069686.31472.C5. View